NCT01850888 2025-12-18MIBG for Refractory Neuroblastoma and PheochromocytomaMasonic Cancer Center, University of MinnesotaPhase NA Completed15 enrolled
NCT03649438 2024-12-11131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory NeuroblastomaUniversity of Texas Southwestern Medical CenterNo longer available